Search
Invitrogen
Etomidate Recombinant Mouse Monoclonal Antibody (2C3)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Additional Information:
{{banner.description}}
图: 1 / 1
Etomidate Antibody (MA566514) in SDS-PAGE
SDS-PAGE characterization of Etomidate under reducing conditions. Lane M: Protein marker (kDa); Lane ETM: Purified Etomidate Recombinant Monoclonal (Product # MA566514). Etomidate showing heavy chain (~50 kDa) and light chain (~25 kDa). Gels were stained with Coomassie Brilliant Blue R-344.
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
产品信息
MA566514
产品规格
种属反应
Chemical
宿主/亚型
Mouse
/ IgG
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
克隆号
2C3
抗原
Conjugate of ETM hapten and KLH.
偶联物
Unconjugated
Unconjugated
Unconjugated
形式
Liquid
浓度
6 mg/mL
规格
200 µg
纯化类型
Protein G
保存液
PBS
内含物
0.09% sodium azide
保存条件
-20°C
运输条件
Ambient (domestic); Wet ice (international)
RRID
靶标信息
Etomidate is a hypnotic agent primarily used for the induction of anesthesia, functioning as a positive allosteric modulator on the gamma-aminobutyric acid type A receptor, thereby enhancing the inhibitory effects of gamma-aminobutyric acid. This intravenous hypnotic is utilized for anesthesia induction, maintenance, critical care sedation, and treating Cushing's disease. Despite its benefits, etomidate is associated with undesirable effects such as pain on injection, myoclonus, CNS excitation, adrenocortical depression, and postoperative nausea and vomiting. The pharmaceutical design of etomidate aims to address these issues, with ongoing research exploring alternative administration routes and dosage forms to expand its application. While etomidate remains clinically relevant due to its hemodynamic stability and rapid onset and offset, alternatives like propofol, ketamine, and remimazolam are being considered due to fewer side effects.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
